Tech Company Financing Transactions
Acton Pharmaceuticals Funding Round
On 5/20/2013, Acton Pharmaceuticals landed $7 million in financing from private investors.
Transaction Overview
Company Name
Announced On
5/20/2013
Transaction Type
Venture Equity
Amount
$7,000,005
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
225 Cedar Hill St. 115
Marlborough, MA 01752
USA
Marlborough, MA 01752
USA
Phone
Website
Email Address
Overview
Acton is primarily focused on development and commercialization of innovative pharmaceutical products that treat allergic, pulmonary, and other respiratory related diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
John Simon
Chief Financial Officer
Thomas Phair
Chief Medical Officer
Kenneth Newman
Chief Operating Officer
Daniel Kreisler
VP - Operations
Patrick Noland
Browse more venture capital transactions:
Prev: 5/20/2013: Alteryx venture capital transaction
Next: 5/20/2013: Ablative Solutions venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs